Home LiteratureArticle Details
PMID: 18384232 Published · ppublish English Journal Article

Improving defences at the portal of HIV entry: mucosal and innate immunity.

PLoS medicine ·Vol. 5 ·No. 4 ·2008-04-01 ·Pages e81

Shattock RJ, Haynes BF, Pulendran B, Flores J, Esparza J, Working Group convened by the Global HIV Vaccine Enterprise

Abstract

暂无摘要

MeSH Terms
AIDS Vaccines/immunology Dendritic Cells/immunology HIV/immunology HIV Infections/immunology,prevention & control,transmission,virology Humans Immunity, Innate Immunity, Mucosal T-Lymphocytes/immunology Toll-Like Receptors/immunology Virus Internalization
Chemicals
AIDS Vaccines Toll-Like Receptors
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Shattock Robin J
St George's, University of London, London, United Kingdom. Shattock@sgul.ac.uk
Haynes Barton F
Pulendran Bali
Flores Jorge
Esparza José
Working Group convened by the Global HIV Vaccine Enterprise
Investigators
22 investigators, click to expand
Aderem Alan
Bergmeir Lesley
Bradac James
Brenchley Jason
Davis Heather
Hope Tom
Kozlowski Pamela
Le Grand Roger
Lehner Thomas
Letvin Norman
Levy Jay
Mascola John
McElrath Julie
Norris Philip
Passmore Jo-Ann
Quill Helen
Seder Robert
Sekaly Rafick-Pierra
Shacklett Barbara
Tomaras Georgia
Veazey Ronald
Wright Peter
References (47)
47 references, click to expand
  1. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5.
    J Virol. 1998 Jun;72(6):5035-45 PMID: 9573273
  2. Innate signaling and regulation of Dendritic cell immunity.
    Curr Opin Immunol. 2007 Aug;19(4):435-40 PMID: 17629469
  3. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.
    J Virol. 2000 Jun;74(12):5577-86 PMID: 10823865
  4. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection.
    Nat Med. 2003 Jul;9(7):847-52 PMID: 12835704
  5. Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen.
    J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):231-7 PMID: 17693896
  6. A near-infrared cell tracker reagent for multiscopic in vivo imaging and quantification of leukocyte immune responses.
    PLoS One. 2007 Oct 24;2(10):e1075 PMID: 17957257
  7. HIV/AIDS: allied responses.
    Nature. 2007 Sep 6;449(7158):29-30 PMID: 17805280
  8. Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells.
    J Immunol. 2007 Feb 1;178(3):1671-9 PMID: 17237417
  9. HIV vaccines.
    Annu Rev Immunol. 2006;24:227-55 PMID: 16551249
  10. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.
    Science. 2006 Dec 22;314(5807):1936-8 PMID: 17185603
  11. Translating innate immunity into immunological memory: implications for vaccine development.
    Cell. 2006 Feb 24;124(4):849-63 PMID: 16497593
  12. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission.
    Am J Pathol. 1998 Aug;153(2):481-90 PMID: 9708808
  13. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1.
    Immunity. 2007 Feb;26(2):257-70 PMID: 17306567
  14. Current concepts in AIDS pathogenesis: insights from the SIV/macaque model.
    Annu Rev Med. 2007;58:461-76 PMID: 17217334
  15. Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines.
    Immunol Res. 2006;36(1-3):137-46 PMID: 17337774
  16. Generation of gut-homing T cells and their localization to the small intestinal mucosa.
    Immunol Rev. 2007 Feb;215:226-42 PMID: 17291292
  17. The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.
    PLoS Med. 2005 Feb;2(2):e25 PMID: 15740411
  18. Principles of intracellular viral recognition.
    Curr Opin Immunol. 2007 Feb;19(1):17-23 PMID: 17118636
  19. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
    J Exp Med. 2003 Jul 21;198(2):267-79 PMID: 12874260
  20. Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point.
    Blood. 2004 Sep 15;104(6):1784-92 PMID: 15187026
  21. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.
    J Exp Med. 2006 Feb 20;203(2):413-24 PMID: 16461338
  22. Mucosal vaccines: the promise and the challenge.
    Nat Rev Immunol. 2006 Feb;6(2):148-58 PMID: 16491139
  23. Direct and sensitive detection of a human virus by rupture event scanning.
    Nat Biotechnol. 2001 Sep;19(9):833-7 PMID: 11533641
  24. Humoral immunity to HIV-1: neutralization and beyond.
    J Intern Med. 2007 Jul;262(1):5-25 PMID: 17598812
  25. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
    Nature. 2006 Sep 21;443(7109):350-4 PMID: 16921384
  26. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large.
    Annu Rev Immunol. 2006;24:353-89 PMID: 16551253
  27. Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids.
    Inflamm Bowel Dis. 2008 Feb;14(2):275-89 PMID: 17924560
  28. Resolution of de novo HIV production and trafficking in immature dendritic cells.
    Nat Methods. 2008 Jan;5(1):75-85 PMID: 18059278
  29. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
    J Virol. 2003 Nov;77(21):11708-17 PMID: 14557656
  30. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.
    J Virol. 2005 Nov;79(22):14169-78 PMID: 16254352
  31. Pathogen recognition and innate immunity.
    Cell. 2006 Feb 24;124(4):783-801 PMID: 16497588
  32. Fc receptor but not complement binding is important in antibody protection against HIV.
    Nature. 2007 Sep 6;449(7158):101-4 PMID: 17805298
  33. Regulatory T cells (Treg) and HIV/AIDS: summary of the September 7-8, 2006 workshop.
    AIDS Res Hum Retroviruses. 2007 Jul;23(7):945-52 PMID: 17678480
  34. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates.
    J Exp Med. 2006 May 15;203(5):1249-58 PMID: 16636134
  35. gammadelta T cells: novel initiators of adaptive immunity.
    Immunol Rev. 2007 Feb;215:89-102 PMID: 17291281
  36. Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell.
    Virology. 2007 Apr 10;360(2):286-93 PMID: 17123568
  37. The perfect mix: recent progress in adjuvant research.
    Nat Rev Microbiol. 2007 Jul;5(7):505-17 PMID: 17558426
  38. Lymphocyte tracking and interactions in secondary lymphoid organs.
    Inflamm Res. 2007 Oct;56(10):391-401 PMID: 18026695
  39. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18.
    Clin Diagn Lab Immunol. 2005 Aug;12(8):959-69 PMID: 16085914
  40. Self-defense: the fruit fly style.
    Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):429-30 PMID: 9435208
  41. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.
    J Immunol. 2007 Apr 1;178(7):4424-35 PMID: 17372000
  42. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.
    Nat Med. 2000 Feb;6(2):207-10 PMID: 10655111
  43. Nod-like proteins in immunity, inflammation and disease.
    Nat Immunol. 2006 Dec;7(12):1250-7 PMID: 17110941
  44. Target cells in vaginal HIV transmission.
    Microbes Infect. 2003 Jan;5(1):59-67 PMID: 12593974
  45. Linking innate to adaptive immunity through dendritic cells.
    Novartis Found Symp. 2006;279:101-9; discussion 109-13, 216-9 PMID: 17278389
  46. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
    AIDS Res Hum Retroviruses. 2004 Sep;20(9):972-88 PMID: 15585085
  47. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.
    Nature. 2005 Apr 28;434(7037):1148-52 PMID: 15793562
Article Info
Journal
PLoS medicine
Abbr.
PLoS Med
ISSN
1549-1676
DOI
10.1371/journal.pmed.0050081
Email
shattock@sgul.ac.uk
Published
2008-04-01
Pages
e81
Language
English
Region
United States
NLM ID
101231360
PMCID
PMC2276525
Subset
IM
External Links
PubMed source DOI: 10.1371/journal.pmed.0050081 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2